These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1146 related articles for article (PubMed ID: 16011977)

  • 1. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
    Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
    Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack.
    McCabe DJ; Harrison P; Sidhu PS; Brown MM; Machin SJ
    Br J Haematol; 2004 Sep; 126(6):861-9. PubMed ID: 15352991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
    Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
    Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
    Christie DJ; Kottke-Marchant K; Gorman RT
    Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
    Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C
    J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
    Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
    Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
    Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
    J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease.
    Coakley M; Self R; Marchant W; Mackie I; Mallett SV; Mythen M
    Anaesthesia; 2005 Dec; 60(12):1173-8. PubMed ID: 16288614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin.
    Takahashi S; Ushida M; Komine R; Shimizu A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M
    Thromb Res; 2007; 119(4):517-24. PubMed ID: 16793119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.
    Godeneche G; Sorel N; Ragot S; Chomel JC; Neau JP; Macchi L
    Platelets; 2009 Nov; 20(7):471-7. PubMed ID: 19852685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.